Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Medicis Reviews Purchase of Graceway Pharma
Yahoo/Zacks
Saturday, November 26, 2011 - 10:26am
tags:
Medicis, Graceway
Medivation Back to Neutral
Yahoo/Zacks
Saturday, November 26, 2011 - 10:22am
tags:
Medivation, MDV3100, prostate cancer
Inhibitex: The Negatives Of An Acquisition And The Odds Of It Occurring
Seeking Alpha
Saturday, November 26, 2011 - 10:18am
tags:
Inhibitex
4-Star Stocks Poised to Pop: Sequenom
Motley Fool
Saturday, November 26, 2011 - 10:16am
tags:
Sequenom
Looking back at Immunex and ahead to Seattle's biotech future
bizjournals.com
Saturday, November 26, 2011 - 10:15am
tags:
Amgen
Transcept Wins FDA OK For Insomnia Drug, What's Next?
Seeking Alpha
Wednesday, November 23, 2011 - 6:37pm
tags:
Transcept, FDA, insomnia, Intermezzo
DEALTALK-Pfizer likely to spin off animal health -sources
Reuters
Wednesday, November 23, 2011 - 6:36pm
tags:
Pfizer, M&A, animal health
Obama’s Medicare Chief Plans to Resign
Bloomberg
Wednesday, November 23, 2011 - 1:34pm
tags:
Obama, Medicare, Medicaid
Chronic Bowel Disease Drugs Linked to Skin Cancer Risk
Yahoo/Health Day
Wednesday, November 23, 2011 - 1:28pm
tags:
thiopurines, skin cancer, inflammatory bowel disease
Bayer YAZ To Follow Merck's Vioxx?
Injuryboard.com
Wednesday, November 23, 2011 - 1:25pm
tags:
Merck, Yaz, Yasmin, Vioxx
Why Pfizer May Be About to Take Off
Motley Fool
Wednesday, November 23, 2011 - 1:24pm
tags:
Pfizer
Amgen's new Enbrel patent could delay biosims for 17 years
Fierce Pharma
Wednesday, November 23, 2011 - 1:11pm
tags:
Enrbrel, Amgen, biosimilars, Merck, anti-inflammatory
Abbott Wins Ruling On Overtime Pay For Reps
Pharmalot
Wednesday, November 23, 2011 - 1:08pm
tags:
overtime lawsuits, Abbott Laboratories
Merck's $950 Million Settlement Sheds More Light on Rogue Pharma Practices
Minyanville
Wednesday, November 23, 2011 - 1:07pm
tags:
Merck, Vioxx
11 Biotech Stocks With Bullish Short Trends
Seeking Alpha
Wednesday, November 23, 2011 - 11:14am
tags:
Biomarin, BioSpecifics Technologies, Complete Genomics, Incyte, Medivation, Insmed, Momenta, Questcor, Seattle Genetics, Sangamo BioSciences, XenoPort
Don't Get Too Worked Up Over InterMune's Earnings
Motley Fool
Wednesday, November 23, 2011 - 10:42am
tags:
earnings, InterMune
Merck said to hijack German rival's Facebook page
Yahoo/Reuters
Wednesday, November 23, 2011 - 10:39am
tags:
Merck, Merck KGaA, Facebook
Celgene Halts Prostate-Cancer Study for Top-Selling Revlimid
Bloomberg
Wednesday, November 23, 2011 - 9:25am
tags:
prostate cancer, Celgene, Revlimid
Gilead could have had Pharmasset cheap: founder
Reuters
Wednesday, November 23, 2011 - 9:23am
tags:
Pharmasset, Gilead, M&A
Statins safe, even after a decade of use
Reuters
Wednesday, November 23, 2011 - 9:18am
tags:
statins

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.